bone cancer

Bristol Myers pays $100M for a different kind of ADC
BioPharma Dive
Mon, 11/6/23 - 09:54 am
Bristol Myers Squibb
antibody-drug conjugate
bone cancer
blood cancer
Orum Therapeutics
Sierra Oncology records success in late-stage study of bone cancer drug
BioPharma Dive
Tue, 01/25/22 - 10:47 am
Sierra Oncology
bone cancer
clinical trials
This little cancer drug didn’t make it to market
Stat
Sat, 01/9/16 - 10:44 am
Merrion
Orazol
bone cancer
breast cancer
FDA
Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib
Wall Street Cheat Street
Sun, 02/3/13 - 11:59 am
Merck
Odanacatib
osteoporosis
bone cancer
Infinity Pharmaceuticals stock plunges after company stops potential cancer treatment study
Yahoo/AP
Mon, 06/18/12 - 10:56 am
Infinity Pharmaceuticals
bone cancer
saridegib
Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC
Yahoo/BusinessWire
Sun, 11/13/11 - 12:06 pm
prostate cancer
cabozantinib
bone cancer
Exelixis
Amgen drug gets priority review for bone cancer
Marketwatch
Sun, 07/18/10 - 07:46 am
bone cancer
Amgen
FDA
denosumab
Prolia